DEXCOM, INC. Other Non-Current Liabilities
DEXCOM, INC. (DXCM) had Other Non-Current Liabilities of $150.80 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Liabilities, Noncurrent $150.80M.
- 2026-03-31: Other Liabilities, Noncurrent $141.80M.
- 2025-12-31: Other Liabilities, Noncurrent $137.10M.
- 2025-09-30: Other Liabilities, Noncurrent $147.40M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $150.80M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $141.80M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $137.10M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $147.40M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $151.60M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $150.30M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $147.90M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $129.60M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $128.10M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $129.40M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $125.60M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $133.90M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $133.10M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $129.70M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $128.30M 10-K · filed 2024-02-08 | |
| 2022-09-30 | $123.30M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $99.50M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $97.10M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $90.00M 10-K · filed 2023-02-09 | |
| 2021-09-30 | $98.50M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $87.70M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $82.40M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $80.90M 10-K · filed 2022-02-14 | |
| 2020-09-30 | $78.50M 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $35.30M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $20.90M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $20.10M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $17.60M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $17.50M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $18.10M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $20.00M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $19.40M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $19.60M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $18.70M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $18.20M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $16.70M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $16.30M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $17.70M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $16.60M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $14.00M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $12.50M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $4.10M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | $3.90M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $4.20M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $2.40M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $2.00M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $1.50M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $900.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.00M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $1.10M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $1.70M 10-K · filed 2015-02-25 | |
| 2013-09-30 | $2.80M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $3.10M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $2.70M 10-Q · filed 2013-05-01 | |
| 2012-12-31 | $2.10M 10-K · filed 2014-02-20 | |
| 2012-09-30 | $1.57M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $1.55M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $1.50M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $1.00M 10-K · filed 2013-02-21 | $963.00K 10-K · filed 2012-02-23 |
| 2011-09-30 | $985.00K 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $1.02M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $1.04M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |